what glp-1 did serena williams use on Her Weight Loss Journey With a Serena Williams on Her Experience

DISCUSSION The findings of our meta-analysis provide robust evidence for the efficacy and safety of the triple-hormone-receptor agonist retatrutide in obesity treatment

It is being developed by Eli Lilly and Company, and whilst Phase 3 trials are anticipated, no approval timeline has been confirmed

By activating glucagon receptors, retatrutide may increase energy expenditure and influence fat metabolism

Today, studies estimate that over 80 percent of the personalized compounded GLP-1 drugs now being marketed include added ingredients such as B vitamins (B6, B12, B3)

Primary uses: Type 2 diabetes management

Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes